Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06490224 · ClinicalTrials.gov registry record · NA
Measuring and Displaying the Subjective
A NA study of Communication Research and Physician-Patient Relations, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06490224: Completed NA study of Communication Research and Physician-Patient Relations, sponsored by University of Texas at Austin.
NCT06490224 is a NA study of Communication Research and Physician-Patient Relations that has completed, run by University of Texas at Austin. The registered enrollment target is 200 participants, below the 471-participant average among 6 other Communication Research trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06490224, a NA study of Communication Research and Physician-Patient Relations, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators developed a brief set of subjective health measures designed to feel more relevant to patients seeking musculoskeletal specialty care, presented the scores to patients and clinicians using an easy-to-understand visual display, and measured whether or not this process harmed patient experience.
Primary Outcome
Quality of shared decision-making (Numerical scale from 1-27; Higher scores equal better outcome)
Conditions Studied
Interventions
- BEHAVIORAL Relevant Patient Reported Outcome Measures (PROMs)
- OTHER My Whole Health Map
Study Locations (1)
Texas
- University of Texas at Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-11-19 |
| Est. Completion | 2024-04-06 |
| Phase | NA |
What the finished NCT06490224 record still lists
NCT06490224 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 471-participant average among 6 other Communication Research trials with a reported enrollment target (58% lower).
The record links to 2 conditions, with Communication Research appearing as the primary indexed condition, and to 2 interventions - of which Relevant Patient Reported Outcome Measures (PROMs) is the first listed.
NCT06490224 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06490224 about?
NCT06490224 is a clinical study titled "Measuring and Displaying the Subjective". The investigators developed a brief set of subjective health measures designed to feel more relevant to patients seeking musculoskeletal specialty care, presented the scores to patients and clinicians using an easy-to-understand visual display, and measured whether or not this process harmed patient...
What is the current status of trial NCT06490224?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2023-11-19. Estimated completion is 2024-04-06.
What conditions does trial NCT06490224 study?
This clinical trial studies the following conditions: Communication Research, Physician-Patient Relations.
What interventions are being tested in trial NCT06490224?
The interventions under investigation include: Relevant Patient Reported Outcome Measures (PROMs) (BEHAVIORAL), My Whole Health Map (OTHER).
Who is sponsoring clinical trial NCT06490224?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06490224 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Communication Research
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Mastery Learning in Communication Skills
RECRUITING · NA
-
Dime La VerDAD: Verify, Debunk, and Disseminate
RECRUITING · NA
-
Adapted Hospital Discharge Intervention: the CONNECT Pilot
RECRUITING · NA
-
Writing Intervention With Adolescents and Young Adults With Cancer
RECRUITING · NA
-
Advance Care Planning GuideTailored for Primary Care Patients
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI